ClinicalTrials.gg
Sign In

Macular Edema clinical trials

The registry lists 756 studies for Macular Edema across more than 10 countries. 65 are recruiting or about to start. 555 of them are mainly about Macular Edema (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 1,117 studies for Macular Edema. How that becomes 755 here

This page counts the studies the registry files under Macular Edema, and those it files under no condition that list Macular Edemathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,117Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −198List Macular Edema as a condition, but the registry did not file them under itMost often written as “Diabetic Macular Edema” (155), “Diabetic Macular Edema (DME)” (22), and “Central Retinal Vein Occlusion With Macular Edema” (5). The registry filed them under other conditions only, most often Diabetic Retinopathy (98) and Macular Degeneration (39).
  3. −164Match it another way108 name it in the title, 23 in a keyword, and 33 by a synonym or other text the search reads.
  4. 755The count on this page337 of them list Macular Edema in their own words; the registry filed them under no condition.

Get an email when these change. Save the Macular Edema studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
470
Status unknown
103
Terminated
60
Recruiting
44
Withdrawn
31
Active, not recruiting
26

Phase

Phase 2
197
Phase 3
156
Phase 4
127
Phase 1
108
Early Phase 1
5

Where

United States
276
China
71
Germany
66
France
56
Canada
53
United Kingdom
51

Who runs them

Novartis Pharmaceuticals (36) · Allergan (30) · National Eye Institute (NEI) (24) · Hoffmann-La Roche (17) · Shahid Beheshti University of Medical Sciences (17) · Bayer (16) · Genentech, Inc. (11) · Johns Hopkins University (10)

What is being tested here

Drugs under test in Macular Edema studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone21136
Triamcinolone11428
Bevacizumab11226
Triamcinolone Acetonide1817
Nepafenac1314
Bromfenac127
Minocycline103
Dexamethasone phosphate113
Diclofenac103
Adalimumab111

Drug classes tested here Corticosteroids 3 open · Angiogenesis inhibitors 1 open · NSAIDs 1 open

Coming up

19phase 3 studies under way
35studies finish main data collection within a year11 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 44 Macular Edema studies recruiting now, 31 (70%) set no upper age limit and 7 (16%) stop at 75 or younger. 1 (2%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (5%) take healthy volunteers.

Recruiting studies that take each age, of 44
AgeWomenMen
100 (0%)0 (0%)
1837 (84%)37 (84%)
3040 (91%)40 (91%)
4043 (98%)43 (98%)
5043 (98%)43 (98%)
6543 (98%)43 (98%)
7537 (84%)37 (84%)
8534 (77%)34 (77%)

Across all 756 studies, recruiting or not: 6% stop at 75 or younger and 2% at 65; 10% take children; <1% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Macular Edema studies take

Of 65 phase 3 interventional studies under Macular Edema, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 124 mo11–51 · 25 studies——
Phase 1/246 mo23–68 · 16 studies——
Phase 219 mo15–32 · 50 studies18 mo14–28 · 32 studies—
Phase 325 mo18–38 · 65 studies24 mo18–33 · 52 studies—
Phase 426 mo15–43 · 63 studies—28 mo15–43 · 51 studies
Interventional, no phase21 mo9–37 · 50 studies—21 mo10–42 · 46 studies
Observational25 mo12–52 · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 756. Browse all 756 → or search them.